Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

8126 items · filings · clear filters

  • SEC EDGAR•filings
    8-K - Distribution Solutions Group, Inc. (0000703604) (Filer)

    Distribution Solutions Group, Inc. filed a Form 8-K on October 5, 2026, including a Regulation FD disclosure and accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Matador Resources Co (0001520006) (Filer)

    Matador Resources filed an 8-K on Oct 5, 2026 reporting completion of an acquisition or disposition of assets, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - HARROW, INC. (0001360214) (Filer)

    Harrow, Inc. filed a Form 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - PTC INC. (0000857005) (Filer)

    PTC Inc. filed a Form 8-K on October 5, 2026, reporting a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K/A - Processa Pharmaceuticals, Inc. (0001533743) (Filer)

    Processa Pharmaceuticals, Inc. filed a Form 8-K amendment on October 5, 2026 (Accession No. 0001140361-26-038535, 3 MB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

  • SEC EDGAR•filings
    8-K - NEIGHBORHOOD INTELLIGENCE, INC. (0001130713) (Filer)

    Neighborhood Intelligence, Inc. filed a Form 8-K on October 5, 2026 reporting termination of a material definitive agreement, results of operations and financial condition, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - INSMED Inc (0001104506) (Filer)

    INSMED Inc filed a Form 8-K on October 5, 2026 reporting director and officer departures, elections, appointments and related compensation arrangements, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - TIDEWATER INC (0000098222) (Filer)

    Tidewater Inc. filed a Form 8-K reporting entry into a material definitive agreement and the creation of a direct financial obligation or an off-balance-sheet arrangement.

  • SEC EDGAR•filings
    8-K - ADVANCED DRAINAGE SYSTEMS, INC. (0001604028) (Filer)

    Advanced Drainage Systems, Inc. filed a Form 8-K on October 5, 2026, reporting a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Alector, Inc. (0001653087) (Filer)

    Alector, Inc. filed a Form 8-K on October 5, 2026, including a material definitive agreement, operating results, a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Camping World Holdings, Inc. (0001669779) (Filer)

    Camping World Holdings, Inc. filed a Form 8-K on October 5, 2026, providing a Regulation FD disclosure under Item 7.01.

  • SEC EDGAR•filings
    8-K - GEO GROUP INC (0000923796) (Filer)

    GEO Group Inc. filed an 8-K on October 5, 2026, reporting a material definitive agreement, completion of an acquisition or asset disposition, a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - ENTERGY TEXAS, INC. (0001427437) (Filer)

    Entergy Texas, Inc. filed a Form 8-K reporting departures, elections, and appointments of directors or certain officers, along with related compensatory arrangements, under Item 5.02.

  • SEC EDGAR•filings
    8-K - Avery Dennison Corp (0000008818) (Filer)

    Avery Dennison Corp filed an 8-K reporting the departure of certain directors or officers, the election or appointment of new directors and officers, and disclosed compensatory arrangements for those officers.

  • SEC EDGAR•filings
    8-K - NEWS CORP (0001564708) (Filer)

    News Corp filed a Form 8-K on October 5, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - DocGo Inc. (0001822359) (Filer)

    DocGo Inc. filed an 8-K reporting entry into and termination of material definitive agreements, creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, and other events.

  • SEC EDGAR•filings
    8-K - Quanome Technologies, Inc. (0001996192) (Filer)

    Quanome Technologies, Inc. filed a Form 8-K on October 5, 2026, reporting that it has entered into a material definitive agreement.

  • SEC EDGAR•filings
    8-K - Eaton Corp plc (0001551182) (Filer)

    Eaton Corp plc filed a Form 8-K reporting the departure of certain officers, the election or appointment of directors and officers, and related compensatory arrangements for those officers.

  • SEC EDGAR•filings
    8-K - Profusa, Inc. (0001859807) (Filer)

    Profusa, Inc. filed a Form 8-K on October 5, 2026 reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Sino Green Land Corp. (0001433551) (Filer)

    Sino Green Land Corp filed an 8-K with the SEC on Oct. 5, 2026, reporting a material definitive agreement, unregistered equity sales, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - New Fortress Energy Inc. (0001749723) (Filer)

    New Fortress Energy Inc. filed a Form 8-K on October 5 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - OMEGA HEALTHCARE INVESTORS INC (0000888491) (Filer)

    Omega Healthcare Investors Inc. filed a Form 8-K on October 5, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K/A - VERRA MOBILITY Corp (0001682745) (Filer)

    VERRA MOBILITY Corp filed an amended Form 8-K reporting departures, elections, appointments, and compensatory arrangements for certain officers, along with financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Artificial Intelligence Technology Solutions Inc. (0001498148) (Filer)

    Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on October 5, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - Spark I Acquisition Corp (0001884046) (Filer)

    Spark I Acquisition Corp filed a Form 8-K under Item 8.01 (Other Events) with the SEC on October 5, 2026 (Accession No. 0001104659-26-113444).

  • SEC EDGAR•filings
    8-K - EQUITY BANCSHARES INC (0001227500) (Filer)

    Equity BanShares Inc. filed a Form 8-K on October 5, 2026, reporting other events under Item 8.01 and providing financial statements and exhibits under Item 9.01.

  • SEC EDGAR•filings
    8-K - Vistra Corp. (0001692819) (Filer)

    Vistra Corp filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Co-Diagnostics, Inc. (0001692415) (Filer)

    Co-Diagnostics, Inc. filed a Form 8-K on October 5, 2026 reporting that it has submitted certain matters to a vote of its security holders, as disclosed in Item 5.07 of the filing.

  • SEC EDGAR•filings
    8-K - MOBIX LABS, INC (0001855467) (Filer)

    Mobix Labs, Inc. filed a Form 8-K on October 5, 2026 indicating that it has submitted certain matters to a vote of its security holders, as disclosed in Item 5.07 of the filing.

  • SEC EDGAR•filings
    8-K/A - Jasper Therapeutics, Inc. (0001788028) (Filer)

    Jasper Therapeutics, Inc. filed an amended Form 8-K on October 5, 2026, providing updated Item 9.01 financial statements and related exhibits (Accession No. 0001213900-26-106574).